Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel synthesis process of entecavir monohydrate

A technology of monohydrate and entecavir, which is applied in the field of new synthesis technology of entecavir monohydrate, can solve the problems of low yield of entecavir monohydrate, unsuitable for industrial production, extremely high equipment requirements, etc., and achieves low price, easy control and reaction. selective effect

Inactive Publication Date: 2011-10-26
HAINAN WEI KANG PHARMA QIANSHAN
View PDF5 Cites 28 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0021] The synthesis of entecavir monohydrate in the above synthetic routes all has the disadvantages of extremely low yield and difficult operation.
High requirements on equipment, not suitable for industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel synthesis process of entecavir monohydrate
  • Novel synthesis process of entecavir monohydrate
  • Novel synthesis process of entecavir monohydrate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] Example 1: Preparation of 1

[0060] The three-necked flask of preparing 10L is furnished with the atmospheric distillation device of short fractionation column (filler can be added), accepts the anhydrous calcium chloride of 50 grams in the bottle, and is placed in ice-water bath (monomer cyclopentadiene room temperature polymerization, It must be stored at low temperature), and the tail pipe has a drying tower. Add 1500 grams of dicyclopentadiene to the three-necked flask, protect the whole system with a slight nitrogen atmosphere, and slowly raise the temperature to 180°C under stirring, the monomer cyclopentadiene distills out in the receiving bottle, and keep the temperature of the upper gas port of the distillation not exceeding 42°C Finally, about 1200 grams of monomer cyclopentadiene (preserved at low temperature) were obtained.

Embodiment 2

[0061] Embodiment 2: Preparation of 2

[0062] Add 1000ml of anhydrous xylene, 400g of deoxidized surface metal sodium to a 5L three-necked flask in an oil bath, protect it with a little nitrogen, heat up to 120°C under stirring, dissolve the sodium, and stir vigorously to disperse the sodium into sodium sand. Stop stirring, bring the system back to room temperature, solidify the sodium sand, remove the xylene on the surface, replace it with an appropriate amount of anhydrous THF three times, and finally add about 6000ml of anhydrous THF for protection and set aside.

[0063] Under the protection of slight nitrogen, use an ice-water bath to cool the tetrahydrofuran-sodium sand to 0-5°C, slowly add the prepared monomer cyclopentadiene to the tetrahydrofuran-sodium sand system, control the temperature not to exceed 10°C, and drop After that, the ice-water bath was removed, and the temperature was naturally raised to room temperature and stirred for about 3 hours. The sodium sand...

Embodiment 3

[0064] Embodiment 3: Preparation of 3

[0065] Add 2,500 grams of dimethylphenylchlorosilane and 6,000 ml of anhydrous tetrahydrofuran into a 10L reaction kettle, under the protection of a slight nitrogen gas, cool the system to below -70°C, start adding 2 dropwise, and control the dropping temperature below -70°C, After the dropwise addition, keep stirring at -70°C for about 3 hours, TLC detects that the reaction is complete, (developing agent n-hexane), let it naturally warm up to 0°C, slowly add ice water, stir, stand and separate, and use for the organic phase Wash with saturated sodium bicarbonate solution, extract with n-hexane, dry over anhydrous sodium sulfate, and concentrate under reduced pressure at 65°C to finally obtain about 2700 g of dark yellow oil 3.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel synthesis process of entecavir monohydrate. In the method, monomer cyclopentadiene serves as a starting raw material, the entecavir hydrate is prepared by thirteen steps, i.e. salification, silanization, condensation, reduction, resolution, esterification, reduction, desilanization, hydroxyl protection, epoxidation, condensation, allylation, deprotection. According to the invention, raw material is available and is low in price, synthesis operation is simple, reaction conditions are mild and are easy to control, reaction selectivity is good, and yield is high, thus the process is applicable to industrial production.

Description

1. Technical field [0001] The invention relates to a new synthesis process of entecavir monohydrate, belonging to the technical field of entecavir synthesis process. 2. Background technology [0002] Entecavir monohydrate (Entecavir), the chemical name is 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-hydroxymethyl-2-methylenecyclopentane]-1,9- Dihydro-6H-purin-6-ketone monohydrate is a class of cyclopentaneguanosine analogs independently developed by Bristol-Myers Squibb, which is a hepatitis B virus inhibitor. This product was approved by the U.S. Food and Drug Administration (FDA) in March 2005, and its tablet trade name is Baraclude, which was fully launched in China in early 2006. It is suitable for adult chronic hepatitis B patients with active viral replication, persistently elevated alanine aminotransferase (ALT) or active liver lesions. [0003] Entecavir is a potent and selective guanosine analogue with significant activity against hepatitis B virus HBV. Clinical studies hav...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D473/18C07C35/06C07D319/08C07D493/04
Inventor 徐奎汪金灿仲达李祖红郝结兵
Owner HAINAN WEI KANG PHARMA QIANSHAN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com